Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer.
Williams AK, Martínez CH, Lu C, Ng CK, Pautler SE, Chin JL.
Eur Urol. 2011 Sep;60(3):405-10. doi: 10.1016/j.eururo.2010.12.012. Epub 2010 Dec 21.
PMID:21185115
Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
Valerio M, Shah TT, Shah P, Mccartan N, Emberton M, Arya M, Ahmed HU.
Urol Oncol. 2017 Apr;35(4):150.e1-150.e7. doi: 10.1016/j.urolonc.2016.11.008. Epub 2016 Dec 7.
PMID:27955940
Patient-reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy-monitored study.
Tan YG, Law YM, Ngo NT, Khor LY, Tan PH, Ong EHW, Yuen JSP, Ho HSS, Tuan JKL, Kanesvaran R, Gupta RT, Rozen S, Chua MLK, Polascik TJ, Tay KJ.
Prostate. 2023 Jun;83(8):781-791. doi: 10.1002/pros.24517. Epub 2023 Mar 9.
PMID:36895163
Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer.
Ahmad I, Kalna G, Ismail M, Birrell F, Asterling S, McCartney E, Greene D, Davies J, Leung HY.
PLoS One. 2013 Aug 9;8(8):e69243. doi: 10.1371/journal.pone.0069243. eCollection 2013.
PMID:23950886
New technologies and techniques for prostate cancer focal therapy.
Linares-Espinós E, Carneiro A, Martínez-Salamanca JI, Bianco F, Castro-Alfaro A, Cathelineau X, Valerio M, Sanchez-Salas R.